...to jump in again. I can't be angry at this stock, like it too much. Sold out first a few weeks ago at $8.24, but looking sort of tempting
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025